sorted by label

Subject	Predicate
?:N-desalkylquetiapine	?:does_not_inhibit
?:N-desalkylquetiapine_does_not_inhibit_cyp2c9	?:value
?:N-desalkylquetiapine_inhibits_cyp2c9	?:value
?:R-citalopram	?:does_not_inhibit
?:R-citalopram_does_not_inhibit_cyp2c9	?:value
?:R-citalopram_inhibits_cyp2c9	?:value
?:R-demethylcitalopram	?:does_not_inhibit
?:R-demethylcitalopram_does_not_inhibit_cyp2c9	?:value
?:R-demethylcitalopram_inhibits_cyp2c9	?:value
?:S-demethylcitalopram	?:does_not_inhibit
?:S-demethylcitalopram_does_not_inhibit_cyp2c9	?:value
?:S-demethylcitalopram_inhibits_cyp2c9	?:value
?:S-warfarin	?:in_vitro_probe_substrate_of_enzyme
?:S-warfarin	?:primary_total_clearance_enzyme
?:S-warfarin_in_vitro_probe_substrate_of_enzyme_cyp2c9	?:value
?:S-warfarin_primary_total_clearance_enzyme_cyp2c9	?:value
?:amiodarone	?:inhibits
?:amiodarone is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:amiodarone is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:amiodarone_does_not_inhibit_cyp2c9	?:value
?:amiodarone_inhibits_cyp2c9	?:value
?:aripiprazole	?:does_not_inhibit
?:aripiprazole	?:is_not_substrate_of
?:aripiprazole_does_not_inhibit_cyp2c9	?:value
?:aripiprazole_inhibits_cyp2c9	?:value
?:aripiprazole_is_not_substrate_of_cyp2c9	?:value
?:aripiprazole_substrate_of_cyp2c9	?:value
?:atazanavir	?:does_not_inhibit
?:atazanavir_does_not_inhibit_cyp2c9	?:value
?:atazanavir_inhibits_cyp2c9	?:value
?:atomoxetine	?:does_not_inhibit
?:atomoxetine_does_not_inhibit_cyp2c9	?:value
?:atomoxetine_inhibits_cyp2c9	?:value
?:atorvastatin_is_not_substrate_of_cyp2c9	?:value
?:atorvastatin_substrate_of_cyp2c9	?:value
?:celecoxib	?:does_not_inhibit
?:celecoxib	?:substrate_of
?:celecoxib_does_not_inhibit_cyp2c9	?:value
?:celecoxib_inhibits_cyp2c9	?:value
?:celecoxib_is_not_substrate_of_cyp2c9	?:value
?:celecoxib_substrate_of_cyp2c9	?:value
?:cinacalcet	?:does_not_inhibit
?:cinacalcet_does_not_inhibit_cyp2c9	?:value
?:cinacalcet_inhibits_cyp2c9	?:value
?:citalopram	?:does_not_inhibit
?:citalopram_does_not_inhibit_cyp2c9	?:value
?:citalopram_inhibits_cyp2c9	?:value
?:clarithromycin	?:is_not_substrate_of
?:clarithromycin_is_not_substrate_of_cyp2c9	?:value
?:clarithromycin_substrate_of_cyp2c9	?:value
?:clozapine_inhibition_constant_cyp2c9	?:value
?:cyp2c9_controls_formation_of_4-(4-chlorophenyl)-4-hydroxypiperidine	?:object
?:cyp2c9_controls_formation_of_N-dealkylperphenazine	?:object
?:cyp2c9_controls_formation_of_N-desmethylrosuvastatin	?:object
?:cyp2c9_controls_formation_of_O-desmethylvenlafaxine	?:object
?:cyp2c9_controls_formation_of_hydroxybupropion	?:object
?:cyp2c9_controls_formation_of_threohydrobupropion	?:object
?:cyp2c9_polymorphic_enzyme_True	?:object
?:demethylcitalopram_inhibits_cyp2c9	?:value
?:duloxetine	?:does_not_inhibit
?:duloxetine_does_not_inhibit_cyp2c9	?:value
?:duloxetine_inhibits_cyp2c9	?:value
?:escitalopram	?:does_not_inhibit
?:escitalopram_does_not_inhibit_cyp2c9	?:value
?:escitalopram_inhibits_cyp2c9	?:value
?:eszopiclone	?:does_not_inhibit
?:eszopiclone_does_not_inhibit_CYP2C9	?:value
?:eszopiclone_inhibits_CYP2C9	?:value
?:fluconazole	?:inhibits
?:fluconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:fluconazole is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:fluconazole_does_not_inhibit_cyp2c9	?:value
?:fluconazole_inhibits_cyp2c9	?:value
?:fluvastatin	?:primary_total_clearance_enzyme
?:fluvastatin	?:substrate_of
?:fluvastatin_is_not_substrate_of_cyp2c9	?:value
?:fluvastatin_primary_total_clearance_enzyme_cyp2c9	?:value
?:fluvastatin_substrate_of_cyp2c9	?:value
?:fluvoxamine	?:inhibits
?:fluvoxamine is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:fluvoxamine is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:fluvoxamine_does_not_inhibit_cyp2c9	?:value
?:fluvoxamine_inhibits_cyp2c9	?:value
?:iloperidone	?:is_not_substrate_of
?:iloperidone_is_not_substrate_of_cyp2c9	?:value
?:iloperidone_substrate_of_cyp2c9	?:value
?:indinavir	?:does_not_inhibit
?:indinavir_does_not_inhibit_cyp2c9	?:value
?:indinavir_inhibits_cyp2c9	?:value
?:mirtazapine	?:does_not_inhibit
?:mirtazapine_does_not_inhibit_cyp2c9	?:value
?:mirtazapine_inhibits_cyp2c9	?:value
?:montelukast	?:does_not_inhibit
?:montelukast_does_not_inhibit_cyp2c9	?:value
?:montelukast_inhibits_cyp2c9	?:value
?:nefazodone_is_not_substrate_of_cyp2c9	?:value
?:nefazodone_substrate_of_cyp2c9	?:value
?:olanzapine_inhibition_constant_cyp2c9	?:value
?:paliperidone	?:does_not_inhibit
?:paliperidone_does_not_inhibit_cyp2c9	?:value
?:paliperidone_inhibits_cyp2c9	?:value
?:quetiapine	?:does_not_inhibit
?:quetiapine_does_not_inhibit_cyp2c9	?:value
?:quetiapine_inhibits_cyp2c9	?:value
?:quetiapine_is_not_substrate_of_cyp2c9	?:value
?:quetiapine_substrate_of_cyp2c9	?:value
?:rosiglitazone	?:does_not_inhibit
?:rosiglitazone_does_not_inhibit_cyp2c9	?:value
?:rosiglitazone_inhibits_cyp2c9	?:value
?:rosuvastatin	?:primary_metabolic_clearance_enzyme
?:rosuvastatin_primary_metabolic_clearance_enzyme_cyp2c9	?:value
?:sulfinpyrazone_in_vitro_selective_inhibitor_of_enzyme_cyp2c9	?:value
?:sulphaphenazole_in_vitro_selective_inhibitor_of_enzyme_cyp2c9	?:value
?:tamoxifen	?:substrate_of
?:tamoxifen_is_not_substrate_of_cyp2c9	?:value
?:tamoxifen_substrate_of_cyp2c9	?:value
?:teriflunomide is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:teriflunomide is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:teriflunomide_does_not_inhibit_cyp2c9	?:value
?:teriflunomide_inhibits_cyp2c9	?:value
?:tolbutamide	?:in_vitro_probe_substrate_of_enzyme
?:tolbutamide	?:primary_total_clearance_enzyme
?:tolbutamide_in_vitro_probe_substrate_of_enzyme_cyp2c9	?:value
?:tolbutamide_primary_total_clearance_enzyme_cyp2c9	?:value
?:topiramate	?:does_not_inhibit
?:topiramate_does_not_inhibit_cyp2c9	?:value
?:topiramate_inhibits_cyp2c9	?:value
?:venlafaxine	?:does_not_inhibit
?:venlafaxine_does_not_inhibit_cyp2c9	?:value
?:venlafaxine_inhibits_cyp2c9	?:value
?:voriconazole	?:inhibits
?:voriconazole	?:substrate_of
?:voriconazole is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:voriconazole is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:voriconazole-N-oxide_does_not_inhibit_cyp2c9	?:value
?:voriconazole-N-oxide_inhibits_cyp2c9	?:value
?:voriconazole-n-oxide is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:voriconazole-n-oxide is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:voriconazole_does_not_inhibit_cyp2c9	?:value
?:voriconazole_inhibits_cyp2c9	?:value
?:voriconazole_is_not_substrate_of_cyp2c9	?:value
?:voriconazole_substrate_of_cyp2c9	?:value
?:warfarin	?:primary_total_clearance_enzyme
?:warfarin_primary_total_clearance_enzyme_cyp2c9	?:value
?:zafirlukast	?:inhibits
?:zafirlukast	?:substrate_of
?:zafirlukast is predicted to reduce the clearance of fluvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:zafirlukast is predicted to reduce the clearance of rosuvastatin by inhibition of CYP2C9	?:EnzymeInhibited
?:zafirlukast_does_not_inhibit_cyp2c9	?:value
?:zafirlukast_inhibits_cyp2c9	?:value
?:zafirlukast_is_not_substrate_of_cyp2c9	?:value
?:zafirlukast_substrate_of_cyp2c9	?:value
?:ziprasidone	?:does_not_inhibit
?:ziprasidone_does_not_inhibit_cyp2c9	?:value
?:ziprasidone_inhibits_cyp2c9	?:value
?:ziprasidone_is_not_substrate_of_cyp2c9	?:value
?:ziprasidone_substrate_of_cyp2c9	?:value